Preliminary program

Day One _ September 24, 2024

9:00 - 9:30 - Reception 


Keynote Lecture 

9:30 - 10:30 – Mathieu Lupien, Senior scientist, Princess Margaret Cancer Centre, University Health Network, Professor University of Toronto, Canada  

  • Decoding intra-tumour heterogeneity from chromatin variants

 

SESSION 1) Epigenetic players of cancer gene regulation

 

10:30 - 11:00 - Pierre-Antoine Defossez, Group leader, CNRS
Research Scientist, Epigenetics and cell fate Lab, Paris, France

  • Dynamics and interpretation of DNA methylation in mammals  

 
11:00 - 11:30 - Coffee break and posters session

11:30 - 12:00 - Céline Vallot, Research Scientist, Head of the Dynamics of Epigenetic Plasticity group at Institut Curie, Paris, France

  • Mechanisms of cell plasticity in triple negative breast cancer


12:00 - 12:30 -Short oral communications

12:30 - 2:00 - Lunch break and meet the speakers

2:00 - 2:30 - Charlotte Proudhon, INSERM Investigator
Group leader, IRSET, Research Institute for Environmental and Occupational Health, Rennes, France

  • Non-invasive multi-cancer diagnosis targeting LINE-1 retrotransposons reactivation

                                                                         

2:30 - 3:00 - Short oral communications       
    
3:00 - 3:10 - Active Motif Sponsor talk
                                                            

3:10 - 3:40  - Coffee break and posters session 

SESSION 2) When Epigenetics met Chemistry?

 

3:40 - 4:10 - Marie Lopez,  Institut des biomolécules Max Mousseron (IBMM), CNRS-Univ. Montpellier-ENSCM UMR5247, France

  • Multifunctional chemical compounds to target epigenetic mechanisms in cancer

 
4:10 - 4:40 - Elena Bochenkova,  MD, Research scientist at Department of Biochemistry, University of Zurich, Switzerland

  • Targeting METTL3 as a novel therapeutic strategy for acute myeloid leukemia


4:40 - 4:55 - Short oral communication

SESSION 3) Making sequencing reads readable 

4:55 - 5:25 - Luca Cozzuto, Senior Bionformatician at the Bionformatics Technology Unit, Barcelona, Spain 

  • MasterOfPores3: a suite of pipelines for nanopore sequencing data


5:25 - 5:40 - Short oral communication                                                                              

Enjoy some free time to visit Nantes

    

8:00  - Gala Dinner (an option at the time of registration)

Day Two _ September 25, 2024



Keynote Lecture 

9:00 - 10:00 – Maite Huarte, Director of DNA and RNA Medicine Division and Head of the Noncoding RNA and Cancer Genome Lab at CIMA, Univ. of Navarra,  Pamplona, Spain

  • Noncoding RNA in preserving genomic stability


SESSION 4) : Epiregulation by non coding RNAs in cancer 

10:00  – 10:30 - Eleonora Leucci, Professor at KU Leuven, Belgium

  • Adaptation to anticancer therapy: to be or not to be coding that’s the question

 

10:30 - 11:00 - Coffee break and posters session

11:00 - 11:30 - Rory Johnson, Associate professor, University College of Dublin, Ireland

  • Non-protein coding RNA drivers of tumorigenesis


11:30 - 11:45 - Short oral communication

11:45 - 11:55 - Diagenode sponsor talk

11:55 - 12:05 - sponsor talk

12:05 - 1:20 - Lunch break and meet the speakers

1:20 - 1:50 - Francesco Nicassio, Center Coordinator - Senior Researcher Tenured, Center for Genomic Science of IIT@SEMM (CGS), Milan, Italy

  • Cellular and molecular heterogeneity in human cancer


1:50 - 2:20 - Antonin Morillon, Research scientist, Group leader at Institut Curie, CNRS, Sorbonne University, PSL, UMR3244, Paris

  • Dark genome and cancer


2:20 - 2:50 - Short oral communications
 

2:50 - 3:20  - Coffee break and posters session

SESSION 5) Epitranscriptomics and Cancer 

3:20 – 3:50 - Sandra Blanco, Research Scientist, CSIC,  Head of Epitranscriptomics and Cancer Lab, Salamanca, Spain

  • Targeting RNA methylases in cancer


3:50 - 4:20 - Isabel Barragan, Ph.D. Scientist and Group Leader of Translational Research in Cancer Immunotherapy and Epigenetics in Research Institute of Malaga and BIONAND platform and Group of Pharmacoepigenetics at Karolinska Institutet, Stockholm, Sweden

  • Epitranscriptomic regulation of response to Immune Checkpoint Blockade


4:20 - 4:50 - Short oral communications

4:50 - 5:00 - Concluding remarks and prizes for young researchers

End of the congress